Some studies indicated that patients with non-small cell lung carcinoma [2], colorectal carcinoma [3], and gastric carcinoma [4], showed expression of GLUT1 and were associated with enhanced tumor aggressiveness and poor survival. The gene discussed is SLC2A1; the disease is neoplasm.